ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

GANX Gain Therapeutics Inc

2.9582
-0.0018 (-0.06%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Gain Therapeutics Inc GANX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0018 -0.06% 2.9582 08:57:26
개장가 저가 고가 종가 전일 종가
2.99 2.82 3.025 2.85 2.96
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202422:25GLOBEGain Therapeutics Announces Positive Results from the Single..
08/04/202422:25GLOBEGain Therapeutics Bolsters Management Team with the..
01/04/202422:25GLOBEGain Therapeutics Strengthens Management Team and Appoints..
26/03/202421:00GLOBEGain Therapeutics Reports Financial Results for Year End..
16/03/202403:30GLOBEGain Therapeutics to Present at Public Ventures Discovery..
05/03/202422:00GLOBEGain Therapeutics Presents Data at the AD/PD™ 2024..
28/02/202404:00GLOBEGain Therapeutics Announces the Initiation of the Multiple..
22/02/202421:00EDGAR2Form 8-K - Current report
15/02/202402:29GLOBEGain Therapeutics Announces 2024 R&D Update on Parkinson’s..
06/02/202423:56GLOBEUPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
06/02/202422:00GLOBEGain Therapeutics’ GT-02287 Completely Restores Motor..
01/02/202407:26EDGAR2Form 8-K - Current report
31/01/202422:00GLOBEGain Therapeutics’ CEO Matthias Alder Issues Letter to..
03/01/202406:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/01/202422:00GLOBEGain Therapeutics Announces Acceptance of Late-Breaking..
02/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
20/12/202306:52EDGAR2Form S-1 - General form for registration of securities under..
01/12/202322:00GLOBEGain Therapeutics Announces Preclinical Data Showing..
29/11/202322:00GLOBEGain Therapeutics to Participate in AI Driven Drug Discovery..
25/11/202303:01GLOBEGain Therapeutics Announces Closing of $10.1 Million Public..
24/11/202320:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/11/202307:27EDGAR2Form 8-K - Current report
21/11/202322:54GLOBEGain Therapeutics Announces Pricing of $9.4 Million Public..
21/11/202306:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/11/202306:03GLOBEGain Therapeutics Announces Proposed Public Offering
18/11/202306:27EDGAR2Form 8-K - Current report
15/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202306:02EDGAR2Form 8-K - Current report
14/11/202321:00GLOBEGain Therapeutics Announces Third Quarter 2023 Financial..
04/10/202320:00GLOBEGain Therapeutics Announces Dosing of First Two Subjects in..
26/09/202305:05GLOBEGain Therapeutics to Participate at Cantor Fitzgerald Global..
21/09/202305:05GLOBEGain Therapeutics to Present at the Cambridge Healthtech..
12/09/202322:25GLOBEGain Therapeutics Receives Approval to Commence Phase 1..
11/08/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:02EDGAR2Form 8-K - Current report
10/08/202320:00GLOBEGain Therapeutics Announces Second Quarter 2023 Financial..
07/08/202320:00GLOBEGain Therapeutics Announces Acceptance of Late Breaking..
31/07/202321:00GLOBEGain Therapeutics to Participate in the 2023 BTIG Virtual..
01/06/202321:00GLOBEGain Therapeutics to Present at the Jefferies Healthcare..
12/05/202321:00GLOBEGain Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock